Highlights
IIA supported (ever)1 patentProfile claimed by owner
About
Using Precision Genomic AI to Predict and Prevent Heart Disease
OpenDNA is developing an AI platform that combines clinical and genomic data analysis for polygenic diseases. The platform allows healthcare providers and payers to easily apply genomic precision medicine and population genomics approaches. Its prediction models help identify high risk patients and their key (or targeted) prevention strategies. The company has already implemented its AI solutions for cardiometabolic syndrome, and in the future means to apply the technology to other complex polygenic disease states, such as cancer; chronic kidney failure; and autoimmune, neurological, and musculoskeletal diseases.
Identity
| Name | OpenDNA |
|---|---|
| Slug | opendna |
| Type / kind | startup |
| Source _id | agxzfmlsbGlzdHNpdGVyGAsSC05ld19Db21wYW55GICA4Jmg1J8JDA |
Status
| Status | active |
|---|---|
| Last update | 2026-05-17 |
Location
| HQ country code | IL |
|---|---|
| HQ region/district | North District |
| HQ city | Haifa |
| HQ address | Netiv HaOr 1, Haifa, Israel |
Web & social
| Website | https://www.open-dna.com |
|---|---|
| https://www.linkedin.com/company/75003430 |
Classifications
Primary sector Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesDigital HealthcareMedical Decision Support
Technologies
BiologicalsGenesArtificial IntelligenceMachine Learning
Target customers
Healthcare & Life SciencesHealthcareProvidersInsurance Companies
Business models
B2B
Tags
blood-pressurechronic-diseasehealthcare-providerscardiovasculardigital-healthcareartificial-intelligencepatientsheart-diseasespersonalized-medicinemhealthdiabetesgeneticsheart-failure
Funding
| Total raised | $2.5M |
|---|---|
| Current stage | Seed |
Raw source document
Show full JSON (0 KB)
{
"0": "s",
"1": "l",
"2": "i",
"3": "m",
"4": "p",
"5": "a",
"6": "g",
"7": "e",
"8": "s",
"9": "_",
"10": "i",
"11": "m",
"12": "p",
"13": "o",
"14": "r",
"15": "t"
}